Sørensen H, Rasmussen P, Sato K, Persson S, Olesen N D, Nielsen H B, Olsen N V, Ogoh S, Secher N H
Department of Anaesthesiology, The Copenhagen Muscle Research Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Br J Anaesth. 2014 Sep;113(3):452-8. doi: 10.1093/bja/aet481. Epub 2014 Feb 6.
Phenylephrine and ephedrine affect frontal lobe oxygenation ([Formula: see text]) differently when assessed by spatially resolved near infrared spectroscopy. We evaluated the effect of phenylephrine and ephedrine on extra- vs intra-cerebral blood flow and on [Formula: see text].
In 10 healthy males (age 20-54 yr), phenylephrine or ephedrine was infused for an ∼20 mm Hg increase in mean arterial pressure. Cerebral oxygenation (SavO₂) was calculated from the arterial and jugular bulb oxygen saturations. Blood flow in the internal carotid artery (ICAf) and blood flow in the external carotid artery (ECAf) were assessed by duplex ultrasonography. Invos-5100c (SinvosO₂) and Foresight (SforeO₂) determined [Formula: see text] while forehead skin oxygenation (SskinO₂) was assessed.
Phenylephrine reduced SforeO₂ by 6.9% (95% confidence interval: 4.8-9.0%; P<0.0001), SinvosO₂ by 10.5 (8.2-12.9%; P<0.0001), and ECAf (6-28%; P=0.0001), but increased ICAf (5-21%; P=0.003) albeit with no consequence for SskinO₂ or SavO₂. In contrast, SforeO₂ was maintained with administration of ephedrine while SinvosO₂ and SavO₂ decreased [by 3.1 (0.7-4.5%; P=0.017) and 2.1 (0.5-3.3%; P=0.012)] as arterial carbon dioxide pressure decreased (P=0.003). ICAf was stable and ECAf increased by 11 (4-18%; P=0.005) with administration of ephedrine while SskinO₂ did not change.
The effect of phenylephrine on ScO₂ is governed by a decrease in external carotid blood flow since it increases cerebral blood flow as determined by flow in the internal carotid artery. In contrast, ScO₂ is largely maintained with administration of ephedrine because blood flow to extracerebral tissue increases.
当通过空间分辨近红外光谱法评估时,去氧肾上腺素和麻黄碱对额叶氧合([公式:见原文])的影响不同。我们评估了去氧肾上腺素和麻黄碱对脑外与脑内血流以及对[公式:见原文]的影响。
在10名健康男性(年龄20 - 54岁)中,输注去氧肾上腺素或麻黄碱以使平均动脉压升高约20 mmHg。根据动脉和颈静脉球氧饱和度计算脑氧合(SavO₂)。通过双功超声评估颈内动脉(ICAf)血流和颈外动脉(ECAf)血流。Invos - 5100c(SinvosO₂)和Foresight(SforeO₂)测定[公式:见原文],同时评估前额皮肤氧合(SskinO₂)。
去氧肾上腺素使SforeO₂降低6.9%(95%置信区间:4.8 - 9.0%;P < 0.0001),SinvosO₂降低10.5(8.2 - 12.9%;P < 0.0001),ECAf降低(6 - 28%;P = 0.0001),但使ICAf增加(5 - 21%;P = 0.003),尽管对SskinO₂或SavO₂无影响。相比之下,麻黄碱给药时SforeO₂得以维持,而随着动脉二氧化碳分压降低(P = 0.003),SinvosO₂和SavO₂降低[分别为3.1(0.7 - 4.5%;P = 0.017)和2.1(0.5 - 3.3%;P = 0.012)]。麻黄碱给药时ICAf稳定,ECAf增加11(4 - 18%;P = 0.005),而SskinO₂未改变。
去氧肾上腺素对ScO₂的影响取决于颈外血流的减少,因为它会增加由颈内动脉血流所确定的脑血流。相比之下,麻黄碱给药时ScO₂基本得以维持,因为流向脑外组织血流增加。